NJ Governor Christie Approves Biosimilars Legislation

New Jersey Governor Christie Approves Biosimilars Legislation — Making Biological Drug Alternatives More Widely Available TRENTON, NJ (November 10, 2015) – New Jersey Governor Chris Christie approved biosimilars legislation today, ensuring patient safety as they access this new category of FDA-approved biologic medicines. “We applaud the Governor for supporting this legislation,” said Debbie Hart, President… Read the full article


Senate Health, Human Services and Senior Citizens Committee Approves Biosimilars Legislation Unanimously

TRENTON, NJ (June 9, 2015) – Legislation that allows for greater Patient access to more affordable FDA-approved biologic medicines was approved unanimously by the Senate Health, Human Services and Senior Citizens Committee. The bill now moves to review by the full Senate. “This legislation, over a year in the making, represents a thoughtful, balanced approach to… Read the full article


Unanimous Approval of A2477 – Making Biological Drug Alternatives More Widely Available

TRENTON, NJ (May 14, 2015) — BioNJ, The Gateway to Health, is pleased with the passage of A2477, legislation that will allow greater Patient access to more affordable FDA-approved biologic medicines. Biological medicines are vital to the treatment of conditions such as cancer, diabetes, infectious diseases and a variety of immune disorders. BioNJ’s rallying cry… Read the full article


Biosimilars

Introduced earlier this year by Assemblywoman Pamela Lampitt, Assembly Bill No. 2477 outlines the guidelines that will govern the prescribing and dispensation of biosimilar products in New Jersey.  As required by the Affordable Care Act, every state is required to implement biosimilar guidelines. As part of its advocacy efforts, BioNJ has teamed up with Discovering… Read the full article